AI assistant
BICYCLE THERAPEUTICS PLC — Director's Dealing 2019
May 23, 2019
32777_dirs_2019-05-22_d3b63ac6-ee25-4e84-bfb8-c9af0c0e734d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BICYCLE THERAPEUTICS Ltd (BCYC)
CIK: 0001761612
Period of Report: 2019-05-22
Reporting Person: Skynner Michael (Chief Operating Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 41123 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $8.10 | 2029-03-07 | Ordinary Shares (10464) | Direct | |
| Stock Option (Right to Buy) | $0.01 | 2028-12-13 | Ordinary Shares (49143) | Direct | |
| Stock Option (Right to Buy) | $0.01 | 2028-12-13 | Ordinary Shares (12252) | Direct |
Footnotes
F1: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.2723 to GBP 1.00 as of May 17, 2019. This option is fully vested.
F2: 25% of the shares shall vest on January 1, 2020, and the remaining shall vest in 36 equal monthly installments.
F3: Commencing as of January 23, 2019, 1,757.4 of the shares subject to the option will vest per month through February 1, 2020; commencing March 1, 2020, 1,324.2 of the shares subject to the option will vest per month through March 1, 2021; commencing April 1, 2021,1253.9 of the shares subject to the option will vest per month through June 1, 2021; and commencing July 1, 2021, 886.9 of the shares subject to the option will vest per month through January 1, 2022.
F4: 25% of the shares shall vest on November 1, 2019, and the remaining shall vest in 36 equal monthly installments.